Ona Miller

Ona Miller joined Flagship Pioneering in 2023 and serves as a Senior Associate, where she works with entrepreneurial scientists to originate and advance platform companies spanning human health, agriculture, and sustainability. In this role, she helps define scientific strategy, shape business models, and develop intellectual property for Flagship’s early-stage biotechnology ventures.

Ona is a biotechnology venture builder with expertise spanning molecular biology, biochemistry, microbiology, and translational science. Prior to joining Flagship, Ona held scientific and operational leadership roles across multiple venture-backed biotechnology companies. She contributed to the advancement of therapeutic programs through key stages of growth, including company formation, financing, and development, and has experience building organizations and programs from their earliest stages. Her background spans both foundational scientific discovery and the operational challenges of translating breakthrough science into successful ventures.

Before entering the industry, Ona completed postdoctoral training at Harvard Medical School, where she studied the molecular basis of antibiotic-resistant bacterial pathogens. She earned her Ph.D. in Biochemistry from the University of St Andrews, where her research focused on uncovering the structural and mechanistic principles underlying bacterial protein systems that have since informed widely adopted protein engineering technologies. Ona’s work has been published in leading scientific journals, including Nature and eLife, and presented internationally through invited seminars and conferences.